Skip to content

Released Mar 11, 2015, before the open

10-K filed Mar 11, 2015, 70 days after period end · 0001144204-15-015256

Q4 2014 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income-$4.04MderivedN/M vs Q4 2013N/M vs Q3 2014
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,060,279N/M
Operating Cash Flowderived-$3,963,034N/M
Free Cash Flowderived-$4,001,362N/M

What the release said

The release

Same quarter

MetricQ4 2014derived from reported figuresQ4 2013derived from reported figuresQ4 2012derived from reported figuresQ4 2011
Net Income-$4.04M-$4.39M$5.02M-$5.16K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR